🚀 VC round data is live in beta, check it out!
Anhui Huaren Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Anhui Huaren Health and similar public comparables like Yixintang Pharmaceutical, Aldawaa Medical Services, Medplus Health Services, Selçuk Ecza and more.
Anhui Huaren Health Overview
About Anhui Huaren Health
Anhui Huaren Health Pharmaceutical Co Ltd focuses on the pharmaceutical retail industry and forms a retail chain, retail centralized procurement, retail service, and retail e-commerce system.
Founded
2001
HQ
Employees
6.0K
Website
Sectors
Financials (FY)
EV
$1B
Anhui Huaren Health Financials
Anhui Huaren Health reported last fiscal year revenue of $658M and EBITDA of $74M.
In the same fiscal year, Anhui Huaren Health generated $215M in gross profit, $74M in EBITDA, and $20M in net income.
Anhui Huaren Health P&L
In the most recent fiscal year, Anhui Huaren Health reported revenue of $658M and EBITDA of $74M.
Anhui Huaren Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $658M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $215M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 33% | XXX | XXX | XXX |
| EBITDA | — | XXX | $74M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 11% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 6% | XXX | XXX | XXX |
| Net Profit | — | XXX | $20M | XXX | XXX | XXX |
| Net Margin | — | XXX | 3% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Anhui Huaren Health Stock Performance
Anhui Huaren Health has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Anhui Huaren Health's stock price is $2.88.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | 1.0% | XXX | XXX | XXX | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAnhui Huaren Health Valuation Multiples
Anhui Huaren Health trades at 1.9x EV/Revenue multiple, and 16.5x EV/EBITDA.
Anhui Huaren Health Financial Valuation Multiples
As of March 19, 2026, Anhui Huaren Health has market cap of $1B and EV of $1B.
Equity research analysts estimate Anhui Huaren Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Anhui Huaren Health has a P/E ratio of 57.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 16.5x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 33.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.7x | XXX | XXX | XXX |
| P/E | — | XXX | 57.5x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 20.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Anhui Huaren Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Anhui Huaren Health Margins & Growth Rates
Anhui Huaren Health's revenue in the last fiscal year grew by 19%.
Anhui Huaren Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 19% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 38% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Anhui Huaren Health Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Yixintang Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| Aldawaa Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Medplus Health Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Selçuk Ecza | XXX | XXX | XXX | XXX | XXX | XXX |
| Create SD Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Anhui Huaren Health M&A Activity
Anhui Huaren Health acquired XXX companies to date.
Last acquisition by Anhui Huaren Health was on XXXXXXXX, XXXXX. Anhui Huaren Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Anhui Huaren Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAnhui Huaren Health Investment Activity
Anhui Huaren Health invested in XXX companies to date.
Anhui Huaren Health made its latest investment on XXXXXXXX, XXXXX. Anhui Huaren Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Anhui Huaren Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Anhui Huaren Health
| When was Anhui Huaren Health founded? | Anhui Huaren Health was founded in 2001. |
| Where is Anhui Huaren Health headquartered? | Anhui Huaren Health is headquartered in China. |
| How many employees does Anhui Huaren Health have? | As of today, Anhui Huaren Health has over 6K employees. |
| Is Anhui Huaren Health publicly listed? | Yes, Anhui Huaren Health is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Anhui Huaren Health? | Anhui Huaren Health trades under 301408 ticker. |
| When did Anhui Huaren Health go public? | Anhui Huaren Health went public in 2023. |
| Who are competitors of Anhui Huaren Health? | Anhui Huaren Health main competitors are Yixintang Pharmaceutical, Aldawaa Medical Services, Medplus Health Services, Selçuk Ecza. |
| What is the current market cap of Anhui Huaren Health? | Anhui Huaren Health's current market cap is $1B. |
| What is the current revenue of Anhui Huaren Health? | Anhui Huaren Health's last fiscal year revenue is $658M. |
| What is the current EV/Revenue multiple of Anhui Huaren Health? | Current revenue multiple of Anhui Huaren Health is 1.9x. |
| Is Anhui Huaren Health profitable? | No, Anhui Huaren Health is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.